Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-12-15
1998-02-17
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
514559, A61K 9127
Patent
active
057189170
ABSTRACT:
A method for the treatment of erectile dysfunction comprises instilling intra meatally an aqueous solution containing prostaglandin-containing liposomes and a detergent for lysing the liposomes. A pharmaceutical composition for treating erectile dysfunction comprises a two-component system. The first component comprises a predetermined amount of lyophilized prostaglandin-containing liposomes. The second component comprises a predetermined volume of an aqueous solution containing a detergent, preferably PEG(9) octylphenyl ether, for lysing the liposomes. Dissolution of the lyophilized prostaglandin-containing liposomes yields a liquid composition suitable for application to the penis, preferably intra meatally, to effect erection.
REFERENCES:
patent: 246697 (1881-09-01), Wadleigh
patent: 251355 (1881-12-01), Gibbs
patent: 3993754 (1976-11-01), Rahman et al.
patent: 4114179 (1978-09-01), Ilieve
patent: 4145410 (1979-03-01), Sears
patent: 4235871 (1980-11-01), Papahadjopoulos
patent: 4474773 (1984-10-01), Shinitzky et al.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4493847 (1985-01-01), Mizushima et al.
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4533254 (1985-08-01), Cook et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4610868 (1986-09-01), Fountain et al.
patent: 4677099 (1987-06-01), Shinitzky et al.
patent: 4749585 (1988-06-01), Greco et al.
patent: 4776848 (1988-10-01), Solazzo
patent: 4776991 (1988-10-01), Farmer et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4820732 (1989-04-01), Shell et al.
patent: 4880835 (1989-11-01), Janoff et al.
patent: 4955878 (1990-09-01), See et al.
patent: 4975282 (1990-12-01), Cullis et al.
patent: 5008050 (1991-04-01), Cullis et al.
patent: 5040453 (1991-08-01), Lenk et al.
patent: 5082664 (1992-01-01), Lenk et al.
patent: 5192806 (1993-03-01), Pill et al.
patent: 5242391 (1993-09-01), Place et al.
patent: 5256652 (1993-10-01), El-Rashidy
patent: 5336678 (1994-08-01), Cavallini
patent: 5370613 (1994-12-01), Helmy
patent: 5399581 (1995-03-01), Laragh
patent: 5419763 (1995-05-01), Hildebrand
patent: 5422371 (1995-06-01), Liao et al.
patent: 5474535 (1995-12-01), Place et al.
patent: 5482039 (1996-01-01), Place
patent: 5492911 (1996-02-01), Stief
G. Storm, C. Oussoren, P. Peeters, Y. Barenholz, Tolerability of Liposomes In Vivo, Chapter 22 of Liposome Technology, vol. III.
The Washington Post Parade Magazine, Better Sex for Elders, Mar. 16, 1997.
Porst, et al., Intracavernous Self-Injection Therapy with Prostaglandin El-Results of a Multicenter Study with 189 Patients, 1990.
Stackl, et al., Prostaglandin E1-4 Years Experience of Intracavernous Injection, 1990.
Microfluidics Corp., Laboratory Microfluidizer M-110 Series.
SCRIP No 2036, Jun. 23, 1995, Vivus' MUSE for erectile dysfunction.
Crenshaw, Use of Intraurethral Prostaglandin in the Treatment of Impotence.
Balazsovits, et al, Analysis of the Effect of Liposome Encapsulation on the Vesicant Properties, Acute and Cardiac Toxicities, and Antitumor Efficacy of Doxorubicin, 1989.
Cowens, et al, Initial Clinical (Phase I) Trial of TLC D-99 (Doxorubicin Encapsulated in Liposomes), 1993.
Harvard Scientific Corporation
Kishore Gollamudi S.
LandOfFree
PGE-1 containing lyophilized liposomes for use in the treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PGE-1 containing lyophilized liposomes for use in the treatment , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PGE-1 containing lyophilized liposomes for use in the treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1782457